Research Articles | Page 3 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes Jan 2017 Ther Adv Hematol myelodysplastic syndromes (MDS)
Azacitidine in the management of patients with myelodysplastic syndromes. Dec 2012 Ther Adv Hematol myelodysplastic syndromes (MDS)
Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide Mar 2017 Ther Adv Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes Apr 2023 The Oncologist myelodysplastic syndromes (MDS)
Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes Apr 2023 The Oncologist myelodysplastic syndromes (MDS)
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria Mar 2021 The New England Journal of Medicine paroxysmal nocturnal hemoglobinuria (PNH)
Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Jan 2020 The New England Journal of Medicine myelodysplastic syndromes (MDS)
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial Jun 2019 The Lancet Haematology myelodysplastic syndromes (MDS)
Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency Oct 2019 The Journal of Clinical Investigation paroxysmal nocturnal hemoglobinuria (PNH)
Epidemiology and Pathogenesis of Myelodysplastic Syndrome May 2023 The Cancer Journal myelodysplastic syndromes (MDS)
Share with addtoany.com.